Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Anheuser-Busch InBev NV (ADR) (BUD), Rogers Communications Inc. (USA) (RCI): Good Luck Getting a 10% Return From Your Bond Fund!

Page 1 of 2

The Fed may or may not get their forecast right regarding employment and the timing of QE tapering. But one thing is for certain, they have made it clear that bond funds can lose money very quickly. The iShares Core Total U.S. Bond Market is a proxy for a conservative bond portfolio with 44% in U.S. Treasuries, 31% in mortgage back securities, 24% in investment grade corporate bonds, and 1% in municipal bonds. This fund has lost more than 4% in just two months. And for every 1% increase in interest rates, this fund will lose another 5%. Normally, high coupon payments would be able to cushion the blow against rising rates, but not so here with a weighted average coupon of less than 4%.

Only four companies have a higher corporate credit rating than Apple Inc. (NASDAQ:AAPL). It should be a safe investment, right? The company issued 10-year bonds less than two months ago and investors have already lost more than 7% on this conservative investment. Other asset classes are showing their true colors as well. Commodities are showing they should be used as a byproduct and not for investment purposes. Emerging markets are extremely volatile and are currently suffering enormous losses. Given all this, it still seems to me that developed market equities offer the best risk/reward for investors with a time-frame of ten years or more.

When investing in equities it easy to look at the pain caused during bear markets. This is the emotional fear that should be replaced with an objective outlook. If one takes an objective view of the risk/return then they may see the upside in equities at this juncture in the recovery. The expected return on equities is simply earnings growth plus dividends plus changes in the price-to-earnings ratio. If you buy a high tech flyer at 200x earnings and this ratio falls to 20x, then it is likely that a permanent loss of capital will be the end result. However, if you buy wide-moat stocks with earnings growth of 6-8%, 2-4% dividend yields, and a reasonable P/E multiple then bear market losses will prove to be only temporary.

Happy Hour

Anheuser-Busch InBev NV (ADR) (NYSE:BUD)

Anheuser-Busch InBev NV (ADR) (NYSE:BUD) is the classic definition of a wide-moat stock. The company will make more than $17 billion in EBITDA in 2013, which is roughly twice that of the number two player in SABMiller plc (LON:SAB). They have just completed the Grupo Modelo purchase and ironed out the wrinkles with regulatory agencies. This is a good sign of just how wide ABI’s economic moat is. They own so many key brands, they were forced to let Constellation Brands, Inc. (NYSE:STZ) produce and market Modelo brands in the United States. ABI retains international rights to Modelo and owns more than 17 brands that produce annual sales in excess of $1 billion.

Credit: Anheuser-Busch InBev NV (ADR) (NYSE:BUD)

The operational performance at ABI is off the charts. The company has tremendous operating margins and has continued to grow them via relentless cost cutting and pricing power. Conversely, the two non-alcoholic beverage bellwethers are not even close and their profitability trend is declining.

Anheuser-Busch InBev NV (ADR) (NYSE:BUD) stock has given back more than 12% in recent months. There are two main reasons. First, 3Q12 results were a slight disappointment. Secondly, Brazil is the second most important market for the company and it is facing near-term headwinds. Societe Generale downgraded the stock recently because of the surging U.S. dollar. It has appreciated 13% versus the Brazilian real in recent months.

Neither of these things should matter for patient, long-term investors. Instead, view the company as we discussed above. Consensus is looking for earnings-per-share to advance 9% on average during the next two years to go along with a 2.5% dividend yield. The trailing P/E of 19x is a modest 13% premium to the S&P 500 Index and below many food and beverage peers. It may fluctuate as market sentiment swings, but it is unlikely to find a new permanent depressed level. The end result is that the stock will likely produce an average total return somewhere around 10% over the next market cycle. I don’t know of a bond fund that will be able to achieve 10% returns if interest rates normalize.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!